The Valley Desk

NCT03518203 · Interventional trial

Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients

Overall registry status Completed

Phase 2

Conditions Atypical Hemolytic Uremic Syndrome, Multiple Organ Dysfunction Syndrome, Thrombotic Microangiopathies

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov